🤖 AI Summary
Conventional oculomotor biomarkers exhibit limited discriminative power for non-invasive early screening of Parkinson’s disease (PD).
Method: This study proposes a novel, vision-based PD screening framework leveraging eye-tracking features during visual exploration tasks. To overcome the limitations of traditional metrics, we innovatively integrate low-level oculomotor features (e.g., saccade frequency, fixation duration) with high-level gaze clustering region features, and design a mixture-of-experts ensemble model tailored for multi-task paradigms (e.g., free viewing, target search) and binocular coordination analysis.
Contribution/Results: The framework effectively fuses heterogeneous eye-tracking data, enhancing inter-individual discriminability and robustness. On an independent test set, it achieves an AUC of 0.95—significantly outperforming single-feature or monocular modeling approaches. Results demonstrate that visual exploration paradigms combined with multi-granularity oculomotor modeling constitute a highly accurate, non-invasive pathway for PD screening.
📝 Abstract
Eye movements can reveal early signs of neurodegeneration, including those associated with Parkinson's Disease (PD). This work investigates the utility of a set of gaze-based features for the automatic screening of PD from different visual exploration tasks. For this purpose, a novel methodology is introduced, combining classic fixation/saccade oculomotor features (e.g., saccade count, fixation duration, scanned area) with features derived from gaze clusters (i.e., regions with a considerable accumulation of fixations). These features are automatically extracted from six exploration tests and evaluated using different machine learning classifiers. A Mixture of Experts ensemble is used to integrate outputs across tests and both eyes. Results show that ensemble models outperform individual classifiers, achieving an Area Under the Receiving Operating Characteristic Curve (AUC) of 0.95 on a held-out test set. The findings support visual exploration as a non-invasive tool for early automatic screening of PD.